4 free views remaining today
hereditary spastic paraplegia
ICD-10 Codes
Related ICD-10:
Description
Hereditary Spastic Paraplegia (HSP) is a group of genetic conditions that cause muscle weakness and tightness in the legs, leading to difficulty walking [1]. It's a progressive condition, meaning it worsens over time.
The primary symptom of HSP is spasticity and weakness in the leg muscles, affecting both legs to a relatively similar degree [3]. This can lead to an abnormal gait, decreased mobility, and urinary bladder disturbances [4].
HSP is characterized by gradual weakening of the muscles in the legs, with muscle spasms (spastic weakness) being a common feature [6]. The condition primarily affects the upper motor neurons, which are responsible for controlling voluntary movements [7].
There are different types of HSP, including pure HSP, which is characterized by slowly progressive lower extremity spasticity and weakness, often associated with urinary disturbances and deep sensory loss [8].
HSP is a rare inherited disorder, with the primary symptom being insidiously progressive difficulty walking due to muscle weakness and spasticity [5]. It's essential to note that HSP is not related to spinal cord injuries or other forms of paraplegia.
References: [1] Aug 22, 2024 [3] The primary symptom of HSP is difficulty walking due to spasticity and weakness in the legs. Both legs are affected, usually to a relatively similar degree. [4] Oct 16, 2024 [5] Jul 12, 2017 [6] Hereditary (familial) spastic paraplegia is a group of rare hereditary disorders that cause gradual weakness with muscle spasms (spastic weakness) in the ... [7] Hereditary spastic paraplegia (HSP) is a group of hereditary, degenerative, neurological disorders that primarily affect the upper motor neurons. [8] Pure HSPs are characterized by slowly progressive lower extremity spasticity and weakness, often associated with urinary disturbances, and deep sensory ...
Additional Characteristics
- Hereditary Spastic Paraplegia (HSP) is a group of genetic conditions that cause muscle weakness and tightness in the legs
- spasticity and weakness in the leg muscles
- difficulty walking due to spasticity and weakness in the legs
- muscle spasms (spastic weakness)
- pure HSP, which is characterized by slowly progressive lower extremity spasticity and weakness
- urinary disturbances and deep sensory loss
Signs and Symptoms
Hereditary Spastic Paraplegia (HSP) is a group of rare genetic disorders that affect the nervous system, leading to progressive muscle weakness and stiffness in the legs. The main symptoms of HSP can vary depending on the type and severity of the condition, but here are some common signs and symptoms:
- Leg stiffness and weakness: People with HSP may experience stiffness and weakness in their legs, which can lead to difficulty walking or standing.
- Spasticity: Spasticity is a condition characterized by increased muscle tone, leading to stiffness and rigidity in the affected limbs. This can cause people with HSP to have an abnormal gait or walk with a stiff-legged gait.
- Urinary urgency: Some people with HSP may experience urinary urgency or frequency due to bladder dysfunction.
- Impaired vision: In some cases, HSP can lead to impaired vision due to cataracts and problems with the optic nerve and retina of the eye.
- Ataxia: Ataxia is a lack of muscle coordination that can affect balance and movement. People with HSP may experience ataxia, which can make it difficult to walk or perform other physical activities.
- Epilepsy: In some cases, HSP can be associated with epilepsy, which is characterized by recurrent seizures.
- Cognitive impairment: Some people with HSP may experience cognitive impairment, including memory loss and difficulty with concentration.
- Peripheral neuropathy: Peripheral neuropathy is a condition that affects the nerves outside the brain and spinal cord. People with HSP may experience peripheral neuropathy, which can cause numbness, tingling, or pain in the affected limbs.
- Deafness: In some cases, HSP can be associated with deafness.
It's worth noting that the symptoms of HSP can vary widely depending on the type and severity of the condition. Some people may experience only mild symptoms, while others may have more severe symptoms that significantly impact their quality of life.
References:
- [1] Impaired vision due to cataracts and problems with the optic nerve and retina of the eye · Ataxia, which is a lack of muscle coordination ...
- [3] Aug 22, 2024 — The main symptoms of this type are spasticity and muscle weakness. Complicated hereditary spastic paraplegia: About 10% of people with ...
- [6] The primary symptom of HSP is difficulty walking due to spasticity and weakness in the legs. Both legs are affected, usually to a relatively similar degree.
- [7] Oct 16, 2024 — In pure HSP, symptoms are generally limited to gradual weakening in the legs, urinary bladder disturbance, spasticity, abnormal gait, decreased ...
- [8] In these cases, additional symptoms, including impaired vision, ataxia, epilepsy, cognitive impairment, peripheral neuropathy, and/or deafness, occur. The ...
Additional Symptoms
- Cognitive impairment
- Epilepsy
- Peripheral neuropathy
- Impaired vision
- ataxia
- deafness
- leg weakness
- urinary urgency
- spasticity
Diagnostic Tests
Hereditary spastic paraplegia (HSP) can be diagnosed through a combination of physical examination, neurological evaluation, and various diagnostic tests.
Physical Examination and Neurological Evaluation A healthcare provider will perform a thorough physical exam and neurological evaluation to assess the individual's symptoms, medical history, and family medical history. This is often the first step in diagnosing HSP (3).
Diagnostic Tests Several diagnostic tests may be used to confirm the diagnosis of HSP:
- Genetic Testing: Genetic testing can identify specific genetic mutations associated with HSP. This test utilizes next-generation sequencing to detect single nucleotide and copy number variants in 128 genes associated with hereditary spastic paraplegia (4).
- MRI Scans: MRI scans of the brain and spine may be performed to rule out other conditions that cause similar symptoms, such as multiple sclerosis or spinal cord compression (13).
- Cerebrospinal Fluid Analysis: In some cases, cerebrospinal fluid analysis may be necessary to confirm the diagnosis.
- Blood Tests: Blood tests can be used to check for specific genetic mutations associated with HSP.
Multi-Gene Panels Several multi-gene panels are available that analyze multiple genes associated with HSP. For example:
- The Invitae Hereditary Spastic Paraplegia Comprehensive Panel analyzes 128 genes associated with hereditary spastic paraplegia (2).
- A 75 gene panel is also available, which includes assessment of non-coding variants and is ideal for patients with a clinical suspicion of spastic paraplegia (8).
Specialized Tests In some cases, specialized tests may be necessary to confirm the diagnosis. These can include:
- Athena Diagnostics: Athena Diagnostics offers testing for HSP mutations in five different genes (7).
- Hereditary Spastic Paraplegia Evaluation: This test is specifically designed to evaluate patients with suspected HSP.
It's essential to note that a definitive diagnosis of HSP may require a combination of these diagnostic tests and a thorough medical evaluation. A primary care physician or specialist can help determine the best course of action for an individual's specific situation.
References:
- [3] - How is hereditary spastic paraplegia diagnosed?
- [4] - This test utilizes next-generation sequencing to detect single nucleotide and copy number variants in 128 genes associated with hereditary spastic paraplegia.
- [2] - The Invitae Hereditary Spastic Paraplegia Comprehensive Panel analyzes genes associated with hereditary spastic paraplegia (HSP).
- [8] - A 75 gene panel is also available, which includes assessment of non-coding variants and is ideal for patients with a clinical suspicion of spastic paraplegia.
- [7] - Athena Diagnostics offers testing for HSP mutations in five different genes.
Additional Diagnostic Tests
- Blood Tests
- Genetic Testing
- MRI Scans
- Cerebrospinal Fluid Analysis
- Multi-Gene Panels (e.g., Invitae Hereditary Spastic Paraplegia Comprehensive Panel)
- Specialized Tests (e.g., Athena Diagnostics, Hereditary Spastic Paraplegia Evaluation)
Treatment
Hereditary Spastic Paraplegia (HSP) is a group of genetic conditions that cause progressive muscle weakness and tightness in the legs, with no cure available. However, various drug treatments can help manage symptoms.
Medications for HSP:
- Muscle relaxants such as Baclofen, Tizanidine, Gabapentin/Pregabalin are prescribed to reduce spasticity [8]. These medications can sometimes relieve spasticity and improve mobility.
- Botulinum toxin injections or anesthetics may also be used to manage symptoms [7].
- Other drugs like Rapamycin (RM), N-Acetyl Cysteine (NAC), Guanabenz (GA) have shown moderate efficacy in some studies, but more research is needed to confirm their effectiveness [6].
Important Considerations:
- It's essential to consult a doctor or pharmacist for information regarding drugs, contraindications, and side effects. Possible side effects include drowsiness, dizziness, weakness, confusion, and upset stomach [10].
- In case of emergency or overdose, the local poison control center can be reached at 1 (800) 222-1222.
Current Research:
- Researchers are exploring gene therapy as a potential treatment for HSP. A personalized AAV9-based gene therapy was developed within 3 years from diagnosis and was well tolerated in a phase 1 trial involving a single patient with hereditary spastic paraplegia type 50 [11].
It's essential to note that while these treatments can help manage symptoms, there is no cure for HSP. A multidisciplinary approach, including physical therapy, occupational therapy, and other supportive care, may be necessary to improve quality of life.
References:
[6] by J Arnold · 2024 [7] Jul 19, 2024 [8] Oral medications such as Baclofen, Tizanidine, Gabapentin/Pregabalin are prescribed as muscle relaxants to reduce spasticity. [10] Possible side effects for these drugs include drowsiness, dizziness, weakness, confusion and upset stomach. For information regarding drugs, contraindications and side effects, consult your doctor or pharmacist. [11] In a phase 1 trial in a single patient with hereditary spastic paraplegia type 50, a personalized AAV9-based gene therapy was developed within 3 years from diagnosis and was well tolerated
Recommended Medications
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Hereditary Spastic Paraplegia (HSP) is a group of genetic conditions that lead to progressive muscle tightness and weakness, primarily affecting the legs. When diagnosing HSP, it's essential to consider its differential diagnosis, which includes other conditions that may present similar symptoms.
Conditions to Consider:
- Multiple Sclerosis: A chronic autoimmune disease that affects the central nervous system, causing a wide range of neurological symptoms, including muscle weakness and spasticity [1].
- Structural Abnormalities: Conditions such as syringomyelia, where a fluid-filled cavity forms within the spinal cord, can cause progressive muscle weakness and spasticity [5].
- B12 Deficiency: A deficiency in vitamin B12 can lead to neurological symptoms, including muscle weakness, fatigue, and cognitive impairment [5].
- Adrenomyeloneuropathy: A rare genetic disorder that affects the adrenal glands and spinal cord, causing progressive muscle weakness and atrophy [5].
Key Factors for Differential Diagnosis:
- Age at onset: The age at which symptoms first appear can be an important factor in differentiating HSP from other conditions. For example, if symptoms appear before the age of 20, it may suggest a different underlying cause [8].
- Accompanying clinical features: The presence or absence of additional neurological symptoms, such as bladder involvement or cognitive impairment, can also help differentiate HSP from other conditions [3].
References:
[1] Jul 12, 2017 - HSP syndromes are classified as “complicated” when leg weakness and tightness (spasticity) are accompanied by other neurologic disturbance such ...
[3] by P Opal — HSPs are clinically differentiated into "pure" forms if spastic paraplegia with bladder involvement is the only clinical finding, and " ...
[5] The differential diagnosis includes multiple sclerosis, structural abnormalities involving the spinal cord, B12 deficiency, adrenomyeloneuropathy and other ...
[8] by ST de Bot · 2010 · Cited by 50 — The differential diagnosis of progressive spastic paraplegia strongly depends on the age at onset, as well as the accompanying clinical features ...
Additional Differential Diagnoses
- Adrenomyeloneuropathy
- B12 Deficiency
- Structural Abnormalities
- multiple sclerosis
- obsolete distal hereditary motor neuronopathy type 5A
- autosomal dominant distal hereditary motor neuronopathy 12
- autosomal dominant distal hereditary motor neuronopathy 2
- autosomal recessive distal hereditary motor neuronopathy 4
- autosomal recessive distal hereditary motor neuronopathy 5
- autosomal dominant distal hereditary motor neuronopathy 8
- combined oxidative phosphorylation deficiency 16
- combined oxidative phosphorylation deficiency 3
- combined oxidative phosphorylation deficiency 51
- hereditary spastic paraplegia 84
- obsolete hereditary peripheral neuropathy
- autosomal recessive distal hereditary motor neuronopathy 9
- spastic ataxia 5
- spastic ataxia
- Kennedy's disease
- combined oxidative phosphorylation deficiency
- adult-onset autosomal dominant demyelinating leukodystrophy
- hereditary spastic paraplegia 90B
- torsion dystonia with onset in infancy
- hereditary spastic paraplegia 63
- hereditary spastic paraplegia 77
- autosomal recessive distal hereditary motor neuronopathy 1
- autosomal recessive distal hereditary motor neuronopathy 2
- autosomal recessive distal hereditary motor neuronopathy
- autosomal dominant distal hereditary motor neuronopathy
- autosomal dominant distal hereditary motor neuronopathy 1
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- rdf-schema#comment
- Xref MGI.
- oboInOwl#hasDbXref
- UMLS_CUI:C0037773
- oboInOwl#id
- DOID:2476
- core#notation
- DOID:2476
- IAO_0000115
- A paraplegia that is characterized by progressive stiffness and contraction (spasticity) in the lower limbs.
- oboInOwl#hasExactSynonym
- Strumpell-Lorrain disease
- rdf-schema#label
- hereditary spastic paraplegia
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#NCIthesaurus
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_0112349
- RO_0002452
- http://purl.obolibrary.org/obo/SYMP_0000141
- relatedICD
- http://example.org/icd10/G11.4
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_3073
- owl#annotatedSource
- t418006
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.